Econazole nitrate foam

Drug Profile

Econazole nitrate foam

Alternative Names: Ecoza

Latest Information Update: 04 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Quinnova Pharmaceuticals
  • Developer Exeltis USA Dermatology
  • Class Antifungals; Azoles; Imidazoles; Small molecules
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Tinea pedis

Most Recent Events

  • 15 Jul 2015 Exeltis USA Dermatology has patent protection 5 993 830 for econazole nitrate foam in USA before July 2015
  • 04 Nov 2014 Everett Laboratories is now called Exeltis USA
  • 31 Oct 2014 Quinnova Pharmaceuticals is now called Exeltis USA Dermatology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top